Prospective randomized clinical trial for effect of stellate ganglion block in medically refractory ventricular tachycardia
Not Applicable
- Conditions
- Diseases of the circulatory system
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
1. Over 19 years old or The legal age at which consent for the target can be provided under national law.
2. Patient are diagnosed Refractory Ventricular tachycardia
- Patients who have generated Refractory Ventricular tachycardia despite of defibrillation and drug therapy
- Patients with ICD have generated ICD shock or anti-tachycardia pacing despite of defibrillation and drug therapy
Exclusion Criteria
1. Patients who do not agree with study inclusion
2. Patients who do not taken stellate ganglion block due to unstable hemodynamic status
3. Patients have experienced major hemorrhagic complication
4. Patients of the DNR(do not resuscitate) status
5. Patients with malignancy tumor, major neurogenic disease or gastrointestinal disease
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of frequency changes in persistent ventricular fibrillation that occurred 24 hours before and after treatment began in each group.;Comparison of Frequency Changes in persistent ventricular fibrillation in 5 Days in each group
- Secondary Outcome Measures
Name Time Method mortality;For ICD(implantable cardioverter defibrillator) patients, anti - tachycardia + shock occurrence and frequency;major complication related to stellate ganglion block.